STAT Plus: Pharmalittle: HHS sues Gilead over HIV PrEP pill patents; Purdue and Sacklers shielded from lawsuits until April

Top of the morning to you and a fine one it is. Despite gloomy skies hovering over the Pharmalot campus, we are maintaining a sunny outlook today. And why not? Our short person is sleeping in and our official mascot is almost always sleeping. This leaves us to our own devices, such as they are. First on the list:  firing up the coffee kettle to brew a cup of stimulation; coconut is the choice today, by the way. From there, we will dive into the to-do list. Meanwhile, here are some tidbits for you. Have a lovely day and do keep in touch.

The federal government filed a lawsuit accusing Gilead Sciences (GILD) of infringing patents on a pair of HIV prevention pills and unfairly reaping hundreds of millions of dollars from research funded by taxpayers, STAT reports. The patents are held by the Centers for Disease Control and Prevention, which helped fund academic research into HIV prevention that later formed the basis for two pills sold by the drug maker. The Department of Health and Human Services contended that Gilead refused to reach a licensing agreement.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Pharmalittle: HHS sues Gilead over HIV PrEP pill patents; Purdue and Sacklers shielded from lawsuits until April »